There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, ...
The authors assessed the efficacy and safety of rosuvastatin monotherapy, extended-release (ER) niacin monotherapy, or rosuvastatin and ER niacin combined therapy in patients with atherogenic ...